General
EBF was founded in 2006 at the initiative of 12 pharmaceutical companies, all of them having bioanalytical lab activities in Europe. The goal of bringing these companies together was to implement a platform for discussions of science, day-to-day procedures, business tools, technologies and last but not least regulatory issues. Until 2010, EBF membership was limited to companies involved in bioanalytical activities in a pharmaceutical research and development environment in Europe. From 2011 onwards, the EBF welcomed CROs involved in bioanalytical activities in a pharmaceutical research and development environment in Europe. Currently, the EBF counts 74 members (January 2021). Since 2010, the EBF became a non-profit organisation (vzw) established pursuant to the Belgian Act of 27 June 1921 on non-profit associations, international non-profit associations and foundations.

Steering Committee

The day-to-day management, as well as the representation of the EBF as far as the day-to-day management and external representation is concerned is delegated from the Board of Directors to a Steering Committee assigned by the EBF Chairman.

EBF Mission

• Our mission is to share, discuss, optimize and seek alignment on a broad array of bioanalytical topics including science, procedures, business tools and technology, and regulatory issues.
• Internal discussions within EBF aim to recommend or influence opinions/procedures towards our members, business partners, regulatory bodies and any other stakeholders.
• Going forward, EBF is providing guidance and recommendations to the European and Global bioanalytical community
• Finally, provide development opportunities for EU based scientist by joining cross company collaborations and contributions to peer reviewed journals, international meetings and symposia

Ground rules and apply for membership:

• See membership application form